Artificial Intelligence Diagnoses Brain Tumors in the OR
An NYU Langone neurosurgeon and neuropathologist leverage artificial intelligence to diagnose brain tumors in the operating room.
Caring for Cancer Patients Who Develop Cardiac Complications
NYU Langone’s new multidisciplinary Cardio-Oncology Program detects, monitors, and treats cardiovascular disease caused by cancer treatments.
Coal-Burning Toxins Linked to Greater Heart Disease Risk
NYU Langone study finds exposure to particles found in fossil fuel emissions is associated with an increased risk of death from heart disease.
Drug Targets Folate Receptor in Ovarian Cancer
A clinical trial at NYU Langone’s Perlmutter Cancer Center is testing a highly selective drug for people with platinum-sensitive ovarian cancer.
Early Detection & Intervention Help Keep Woman Melanoma-Free
When 27-year-old Alexa Oberle’s annual skin check revealed a precancerous spot, she was quickly treated by top Long Island skin cancer experts at NYU Langone.
Focused IBD Training Launched for Gastroenterology Fellows
NYU Langone launches national IBD course for first-year gastroenterology fellows, which was held virtually in 2020.
How Oxytocin Makes a Mom
Findings redefine oxytocin as not just a ‘love drug,’ but more as an amplifier and suppressor of neural signals in the brain.
Infectious Diseases and Immunology Fellowship Highlights
... of Medicine • NYU/Bellevue HIV Equity Research Group • SEED Program: Mentorship program for NYU medical ...
Life Support Brings COVID-19 Patients Back from the Brink
By placing gravely ill patients with COVID-19 on life support, NYU Langone doctors give their ravaged lungs time to heal, boosting outcomes.
New Device Treats Liver Tumors Noninvasively
NYU Langone’s device, which dissolves liver tumors with ultrasound in a procedure called histotripsy, is the first in use in New York City.